In This Article:
As global markets navigate the uncertainties surrounding the incoming Trump administration's policies, investors are closely watching sector performances, with financials and energy benefiting from deregulation hopes while healthcare faces challenges. Amidst this backdrop of fluctuating market sentiments and policy shifts, growth companies with high insider ownership can offer unique insights into potential long-term value creation.
Top 10 Growth Companies With High Insider Ownership
| Name | Insider Ownership | Earnings Growth |
| Archean Chemical Industries (NSEI:ACI) | 22.9% | 43% |
| On Holding (NYSE:ONON) | 31% | 29.7% |
| Pharma Mar (BME:PHM) | 11.8% | 56.4% |
| Findi (ASX:FND) | 34.8% | 64.8% |
| Alkami Technology (NasdaqGS:ALKT) | 11% | 98.6% |
| Elliptic Laboratories (OB:ELABS) | 26.8% | 103.6% |
| Credo Technology Group Holding (NasdaqGS:CRDO) | 13.8% | 95% |
| Plenti Group (ASX:PLT) | 12.8% | 107.6% |
| EHang Holdings (NasdaqGM:EH) | 32.8% | 81.4% |
| Brightstar Resources (ASX:BTR) | 16.2% | 84.6% |
Here we highlight a subset of our preferred stocks from the screener.
Oscotec
Simply Wall St Growth Rating: ★★★★★★
Overview: Oscotec Inc. is a biotechnology company involved in drug development, functional materials, and dental bone graft materials, with a market cap of approximately ₩916.74 billion.
Operations: The company generates revenue from its Food Business Division (₩1.69 billion), Medical Business Sector (₩1.63 billion), New Drug Business Division (₩990.90 million), and Functional Materials Division (₩310.71 million).
Insider Ownership: 26.1%
Earnings Growth Forecast: 122% p.a.
Oscotec is forecast to achieve profitability within three years, with earnings expected to grow 122% annually. Despite having limited current revenue (₩5B), its projected revenue growth of 68.9% per year significantly outpaces the Korean market's average. The company's high future Return on Equity of 27.5% reflects strong potential performance. However, its share price has been highly volatile recently, and it trades at a substantial discount to estimated fair value, indicating potential undervaluation opportunities.
-
Click here to discover the nuances of Oscotec with our detailed analytical future growth report.
-
Our expertly prepared valuation report Oscotec implies its share price may be too high.
Norva24 Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Norva24 Group AB (Publ) offers underground infrastructure maintenance services in Northern Europe and has a market cap of SEK5.28 billion.
Operations: The company generates revenue from its underground infrastructure maintenance services in Northern Europe, with total revenue segments amounting to NOK2.45 billion.